Literature DB >> 22507680

Effects of hematopoietic autologous stem cell transplantation to the chronically injured human spinal cord evaluated by motor and somatosensory evoked potentials methods.

A A Frolov1, A S Bryukhovetskiy.   

Abstract

International standards for stem cell treatment of neurological disorders have not yet been established. In particular, specific quantitative methods have not yet been adopted to assess the effectiveness of stem cell treatment. The aim of this study is to evaluate the functional changes detectable by conventional neurophysiologic methods in an injured spinal cord during stem cell therapy. Twenty adult patients with chronic spinal cord injury at C4-C8 level were examined by somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) methods, the first time prior to the treatment and then regularly during its course (1-4 years). The treatment consisted of repeated intrathecal transplantations of autologous hematopoietic stem cells. After at least 1 year of treatment, four effects were detected: 1) restoration of the initially absent short-latency SEP (three patients); 2. N20P23 interpeak amplitude increase in SEP elicited by median nerve stimulation (four patients); 3) P38 latency reduction in SEP elicited by tibial nerve stimulation (two patients); 4) appearance of MEP (three patients). The nonidentical effects of stem cell transplantation in different patients presumably reflect the variety of the regeneration processes in different pathways of the spinal cord, depending on the extent and nature of lesion of the spinal cord pathways in different patients. The local effects of stem cell treatment at the cervical level were evaluated by median SEP and wrist muscle MEP demonstrate the ability of stem cells to spread within the spinal cord at least from lumbar to the cervical level, home there, and participate in the neurorestoration processes.

Entities:  

Mesh:

Year:  2012        PMID: 22507680     DOI: 10.3727/096368912x633761

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  9 in total

Review 1.  Adult stem cells in neural repair: Current options, limitations and perspectives.

Authors:  Eric Domingos Mariano; Manoel Jacobsen Teixeira; Suely Kazue Nagahashi Marie; Guilherme Lepski
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  Electrophysiological Outcome Measures in Spinal Cord Injury Clinical Trials: A Systematic Review.

Authors:  Radha Korupolu; Argyrios Stampas; Mani Singh; Ping Zhou; Gerard Francisco
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

3.  Effectiveness of repeated transplantations of hematopoietic stem cells in spinal cord injury.

Authors:  Andrey S Bryukhovetskiy; Igor S Bryukhovetskiy
Journal:  World J Transplant       Date:  2015-09-24

4.  Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.

Authors:  Junseok W Hur; Tai-Hyoung Cho; Dong-Hyuk Park; Jang-Bo Lee; Jung-Yul Park; Yong-Gu Chung
Journal:  J Spinal Cord Med       Date:  2015-07-24       Impact factor: 1.985

Review 5.  Progress in Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liansheng Gao; Yucong Peng; Weilin Xu; Pingyou He; Tao Li; Xiaoyang Lu; Gao Chen
Journal:  Stem Cells Int       Date:  2020-11-05       Impact factor: 5.443

6.  Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).

Authors:  Hongyun Huang; Wise Young; Lin Chen; Shiqing Feng; Ziad M Al Zoubi; Hari Shanker Sharma; Hooshang Saberi; Gustavo A Moviglia; Xijing He; Dafin F Muresanu; Alok Sharma; Ali Otom; Russell J Andrews; Adeeb Al-Zoubi; Andrey S Bryukhovetskiy; Elena R Chernykh; Krystyna Domańska-Janik; Emad Jafar; W Eustace Johnson; Ying Li; Daqing Li; Zuo Luan; Gengsheng Mao; Ashok K Shetty; Dario Siniscalco; Stephen Skaper; Tiansheng Sun; Yunliang Wang; Lars Wiklund; Qun Xue; Si-Wei You; Zuncheng Zheng; Milan R Dimitrijevic; W S El Masri; Paul R Sanberg; Qunyuan Xu; Guoming Luan; Michael Chopp; Kyoung-Suok Cho; Xin-Fu Zhou; Ping Wu; Kai Liu; Hamid Mobasheri; Seiji Ohtori; Hiroyuki Tanaka; Fabin Han; Yaping Feng; Shaocheng Zhang; Yingjie Lu; Zhicheng Zhang; Yaojian Rao; Zhouping Tang; Haitao Xi; Liang Wu; Shunji Shen; Mengzhou Xue; Guanghong Xiang; Xiaoling Guo; Xiaofeng Yang; Yujun Hao; Yong Hu; Jinfeng Li; Qiang Ao; Bin Wang; Zhiwen Zhang; Ming Lu; Tong Li
Journal:  Cell Transplant       Date:  2018-02       Impact factor: 4.064

Review 7.  Translational Regenerative Therapies for Chronic Spinal Cord Injury.

Authors:  Kyriakos Dalamagkas; Magdalini Tsintou; Amelia Seifalian; Alexander M Seifalian
Journal:  Int J Mol Sci       Date:  2018-06-15       Impact factor: 5.923

8.  Induction of Neurogenesis and Angiogenesis in a Rat Hemisection Spinal Cord Injury Model With Combined Neural Stem Cell, Endothelial Progenitor Cell, and Biomimetic Hydrogel Matrix Therapy.

Authors:  Eric J Marrotte; Khari Johnson; Ryan M Schweller; Rachel Chapla; Brian E Mace; Daniel T Laskowitz; Jennifer L West
Journal:  Crit Care Explor       Date:  2021-06-14

Review 9.  Progress in clinical trials of cell transplantation for the treatment of spinal cord injury: how many questions remain unanswered?

Authors:  Xu-Chang Hu; Yu-Bao Lu; Yong-Na Yang; Xue-Wen Kang; Yong-Gang Wang; Bing Ma; Shuai Xing
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.